Dr. Krochmal is a Board certified Dermatologist with 24+ years experience in the pharmaceutical and consumer goods industries focusing on the development of new products both locally and globally. His most recent role was as Executive Vice President, Research and Product Development for Connetics Corporation, a specialty dermatology company. Dr Krochmal began his career in the pharmaceutical industry following 8 years of private dermatology practice by joining Westwood Pharmaceuticals (the dermatology subsidiary of Bristol-Myers Squibb) in 1983 as Director of Clinical Research. Over the subsequent 10 years, he held several roles of increasing responsibility including VP, Dermatology Research and Development overseeing both preclinical and clinical disciplines, and VP, Worldwide Medical Development providing global support in Biostatistics & Data Management, Human Pharmacology, Drug Safety, Medical Communications and Clinical Study Field Operations to all five Therapeutic Areas of Bristol-Myers Squibb. In 1993, Dr Krochmal joined Unilever PLC, where he spent the next decade in various senior management positions directing the worldwide development of numerous consumer products for the Home and Personal Care Division. Dr Krochmal received his Bachelor of Medical Sciences degree from the University of Wisconsin, his Doctor of Medicine from the Medical College of Wisconsin, and his board certification in dermatology following successful completion of the residency training program at the University of Missouri Medical Center. In 2005, Dr. Krochmal was appointed to the Board of Directors of the International Academy of Cosmetic Dermatology. He is a fellow of the American Academy of Dermatology, a Diplomat of the American Board of Dermatology, and a member of the International Society of Dermatology and the Dermatology Foundation. During his career, Dr Krochmal played a pivotal role in the approval of 15 NDAs/ANDAs for new topical dermatologicals including LacHydrin®, Ultravate®, Dovonex®, Evoclin®, Verdeso®, Olux-E® and Extina®. |